Tamoxifen, Anticancer Drug, Erythrocyte Membrane, Phospholipid Bilayer Tamoxifen is a non steroidal antiestrogen drug extensively used in the prevention and treatment of hormone-dependent breast cancer. To evaluate its perturbing effect upon cell membranes it was made to interact with human erythrocytes and molecular models. These consisted of bilayers of dimyristoylphosphatidylcholine (DMPC) and of dimyristoylphosphatidylethanolamine (DMPE), representative of phospholipids classes located in the outer and inner leaflets of the erythrocyte membrane, respectively. Experiments by fluorescence spectroscopy showed that tamoxifen interacted with DMPC vesicles fluidizing both its polar head and acyl chain regions. These results were confirmed by X-ray diffraction which indi cated that tamoxifen perturbed the same regions of the lipid. However, it did not cause any significant structural perturbation to DMPE bilayers. The examination by electron micro scopy of human erythrocytes incubated with tamoxifen revealed that they changed their normal discoid shape to stomatocytes. According to the bilayer couple hypothesis, this result means that the drug is inserted in the inner leaflet of the erythrocyte membrane. Given the fact that tamoxifen did not interact with DMPE, it is concluded that it interacted with a protein located in the cytoplasmic moiety of the erythrocyte membrane.
Introduction
Tamoxifen, whose structural formula is shown in Fig. 1 , is a non-steroidal antiestrogen drug ex tensively used in the prevention and treatment of hormone dependent breast cancer (Nayfield, 1995; King, 1995; Jordan, 1995) as well as those of the liver, brain and pancreas (Wiseman et al., 1993) . In approximately 30 years since its introduction tamoxifen has been established as the endocrine therapy of choice for estrogen-and progesteronreceptor-positive metastatic breast cancer because of its favorable adverse-effect profile (Higa, 1994; Jaiyesimi et al., 1995) . The mechanisms by which estrogens promote the growth of tumors remain Abbreviations: ER, estrogen receptor; AEBS, antiestro gen binding sites; DMPC, dimyristoylphosphatidylcho line; DMPE, dimyristoylphosphatidylethanolamine; LUV, large unilamellar vesicles; DPH, 1,6-diphenyl-1,3,5-hexatriene; Laurdan. 6-dodecanoyl-2-dimethylaminonaphthalene; r, fluorescence anisotropy; GP. general polarization; SEM, scanning electron microscopy. Reprint requests to Dr. Suwalsky. Fax: 56-41-245974 ; e-mail: msuwalsk@udec.cl. unclear despite nearly half a century investigation. Similarly, are also unclear the mechanisms by which antiestrogens like tamoxifen antagonize the growth of the same tumors (Jaiyesimi et al., 1995; Murphy, 1994; van den Koedijk et al., 1994) . In fact, several mechanisms of action have been pro posed for tamoxifen (van den Koedijk et al., 1994; Coletta et al., 1994) . The one that has found the highest acceptance indicates that its antitumor ac tivity is due to a competition with endogenous estrogen for estrogen receptor (E R ) binding sites (Jaiyesimi et al., 1995; Murphy, 1994; van den Koe dijk et al., 1994) . Thus, the tamoxifen-ER complex would interfere with estrogen-ER mediated gene 0939-5075/ 98/ 0300-0182 $ 06.00 © 1998 Verlag der Z eitschrift für N aturforschung. All rights reserved. D transcription, DNA synthesis, cancer cell growth and growth factors that may be involved in cell proliferation (Jaiyesimi et al., 1995) . However, it has been suggested that besides E R there also high affinity membrane-associated binding sites identified in a variety of tissues called antiestrogen binding sites (A E B S), some of which bind tamoxi fen but not estrogens (van den Koedijk et al., 1994; Coletta et al., 1994; Das et al., 1993) . Another hy pothesis supposes the interaction of tamoxifen with membrane enzymes (Coletta et al., 1994) , particularly with protein kinase C which has been implicated as a key enzyme in cellular growth reg ulation (Eyster and Clark, 1989; O 'Brien et al., 1988; Horgan et al., 1986 ).
An additional subject of controversy is whether tamoxifen effects result from a direct interaction with a relevant protein such as E R (Nayfield, 1995; Borgna, 1994) Luxo et al., 1996) . In fact, as most anticancer agents tamoxifen is a highly lipophilic molecule (Custodio et al., 1991) , likely to accumulate in membrane lipid and protein moieties in route to its target site. Experiments performed on native membranes, liposomes of their lipids or made of synthetic lipids showed that tamoxifen interacts with membranes and affects the physical proper ties of the lipid bilayers (Wiseman, 1993; Custodio et al., 1993; Luxo et al., 1996) . Fluidizing and or dering effects were observed in hydrophobic and hydrophilic regions of the bilayers which, in gene ral, depended on the nature, temperature and physical state of the specimens. Structural effects due to tamoxifen were also observed in mem branes of human breast cancer cells (Clarke et al., 1990) . These effects on membranes have been re lated to antitumor and cytotoxic activities of anti cancer drugs (Balasubramanian et al., 1994) .
Given the controversies surrounding the mecha nism of action of tamoxifen we thought of interest to carry out a study concerning its interaction with cell membranes. This paper describes the results of our studies on the interaction of tamoxifen with human erythrocyte membranes and models consti tuted by phospholipid multilayers and large unila mellar vesicles. These systems have been used in our laboratories to determine the interaction and perturbing effects on membranes by several thera peutical drugs (Suwalsky et al., , 1993 (Suwalsky et al., , 1995 (Suwalsky et al., , 1996 . The multilayers consisted in the phospholipids dimyristoylphosphatidylcholine (DM PC) and dimyristoylphosphatidylethanolamine (D M PE), representative of phospholipid classes located in the outer and inner monolayers of the human erythrocyte membrane, respectively (Devaux and Zachowsky, 1994) . Given the amphipatic character of tamoxifen and both phospholip ids their interactions were assayed in hydrophobic and aqueous media in a wide range of concentra tions. The capacity of tamoxifen to perturb the multilayer structure of DMPC and DM PE was de termined by X-ray diffraction. The effect of ta moxifen in the physical properties of the bilayer of DM PC large unilamellar vesicles was studied evaluating DPH steady state fluorescence anisot ropy and Laurdan fluorescence spectral shifts. In teraction of tamoxifen with human erythrocytes were observed by scanning electron microscopy to detect shape changes induced by the drug.
Materials and Methods

X-ray diffraction analysis o f phospholipid multilayers
Synthetic DMPC (lot 80H-8371 A grade MW 677.9), D M PE (lot 13H-83681 A grade MW 635.9) and tamoxifen (lot 63H-0349 MW 371.5) from Sigma were used without further purification. About 3 mg of each phospholipid were mixed with the corresponding weight of tamoxifen in order to attain DMPC:tamoxifen and DMPE:tamoxifen powder mixtures in the molar ratios of 10:1, 5:1 and 1:1. Each mixture was dissolved in chloroform:methanol 3:1 v/v and left to dry. The recrys tallized samples were placed in special glass capil laries 0.7 mm dia. They were diffracted in DebyeScherrer cameras of 114.6 mm dia and flat-plate cameras with 0.25 mm dia glass collimators pro vided with rotating devices. The same procedure was also followed with samples of each phospho lipid and tamoxifen. The aqueous specimens were prepared in 1.5 mm dia glass capillaries mixing each phospholipid and tamoxifen in the same pro portions as described above. Each capillary was then filled with about 200 uL of distilled water.
These specimens were X-ray diffracted 2 days af ter preparation in flat-plate cameras. Specimen-tofilm distances were 8 and 14 cm, standardized by sprinkling calcite powder on the capillary surface. Ni-filtered CuKa radiation from a Philips PW1140 X-ray generator was used. The relative reflection intensities were obtained from films by peak-integration in a microdensitometer (Joyce-Loebl M K IIIC S) interfaced to a PC. No correction factors were applied. The experiments in water were performed at 17 ± 2 °C, which is below the main transition temperature of both DMPC and DM PE.
Fluorescence measurements on large unilamellar vesicles (LUV)
DMPC LU V suspended in water were prepared by extrusion of frozen and thawed multilamellar liposome suspension (final lipid concentration 0.5 mM) trough two stacked polycarbonate filters of 400 nm pore size (Nucleopore, Corning Costar Corp.) employing nitrogen pressure at 10 °C over the lipid transition temperature. DPH and Laurdan were incorporated into LU V by addition of small aliquots of concentrated solutions of the probe in tetrahydrofurane and ethanol respec tively to LU V suspensions and gently shaken for about 30 min. Fluorescence spectra and anisotropy measurements were respectively performed in a Spex Fluorolog and in a phase shift and modula tion Greg-200 steady-state and time-resolved spectrofluorometer (I. S. S.), both interfaced to computers. Software from I. S. S. were used for data collection and analysis. Measurements of LU V suspensions were made at 18 °C in 10 mm path-length square quartz cuvettes. Sample tem perature was controlled by an external bath circu lator (Cole Parmer) and measured prior and after each measurement using a digital thermometer (Omega). Anisotropy measurements were made in the "L" configuration using prism polarizers (Gian Thompson) in both exciting and emitting beams. The emission was measured across a high pass fil ter (Schott W G-420) with negligible fluorescence. Laurdan fluorescence spectral shifts were quanti fied through the General Polarization (G P) con cept which was evaluated by GP=(Ib-Ir)/(Ib+Ir), where lb and Ir are the intensities at the blue and red edges of the emission spectrum, respectively. These intensities have been measured at the emis sion wavelengths of 440 and 490 nm, which corre spond to the emission maxima of Laurdan in the gel and liquid crystalline phases, respectively (Parasassi and Gratton, 1995) . Tamoxifen was incorpo rated in LU V suspensions by addition of small ali quots of a concentrated ethanolic solution and incubated at 40 °C for ca. 15 min. Samples with probes but without tamoxifen showed no variation in the measured parameters during periods longer than those employed in the experiments. Blank subtraction was performed in all measurements using unlabelled samples without probes. The par tition coefficient of tamoxifen in octanol/buffer pH 7.4, determined by spectrophotometry, was found to be 63.8. This value is close to the reported ratio of tamoxifen concentrations in human nor mal and malignant tissues and in serum during treatment (Lien et al., 1991) .
Scanning electron microscope (SEM) studies on human erythrocytes
The interaction of tamoxifen with human eryth rocytes was achieved by incubating blood samples from clinically healthy male adult donors by punc ture of the ear lobule disinfected with 70% etha nol. Two drops of blood were collected in a plastic tube containing 1 ml of saline solution (0.9% NaCl) at 5 °C. This solution was then used to pre pare the following samples: a) control, by mixing 0.1 ml with 0.9 ml of saline solution, b) one that was 1.5 m M tamoxifen in the aqueous phase and 98.5 mM in the erythrocytes, and c) another tamox ifen solution which was 1 0 -fold as concentrated as that of b), by mixing 0 . 1 ml of blood solution plus 0.9 ml of tamoxifen saline suspensions of adequate concentrations. These samples were incubated at 37 °C for 1 h. They were later fixed with glutaraldehyde adding one drop of each sample to a tube containing 1 ml of 2.5% glutaraldehyde in saline solution, reaching a final fixation concentration of about 2.4% . After resting overnight at 5 °C the fixed samples were directly placed on Al stubs, air dried at 37 °C for half to one h and gold coated for 3 min at 10" 1 Torr in a sputter device (Edwards S150). The observations and photographic records were performed in an Etec Autoscan SEM . The concentrations of tamoxifen in the samples were calculated in base of its 63.8 partition coefficient octanol/buffer 7.4.
Results
X-ray studies on phospholipid multilayers
Given the amphipathic nature of tamoxifen and of the phospholipids DMPC and DM PE, their mo lecular interactions were assayed in hydrophobic and aqueous media. Table I shows the interplanar spacings and relative intensities of the reflections produced by DMPC, tamoxifen and their 10:1, 5:1 and 1 : 1 molar mixtures after their interaction and recrystallization from chloroform:methanol 3:1 v/v solutions. Their corresponding diffractograms are compared in Fig. 2a . The analysis of these results indicated that the X-ray pattern of DMPC was af fected by tamoxifen. In fact, the reflection inten sities of the phospholipid significatively decreased with increasing concentrations of the drug. On the other hand, several new reflections corresponding to tamoxifen showed up in the 5:1 and 1:1 speci mens. It was also observed that the bilayer width of DMPC remained practically constant at 54.5 A. These results clearly indicated that part of tamoxi fen penetrated into the phospholipid bilayer struc ture perturbing its molecular arrangement. Table II and Fig. 2b show the results obtained after DMPC, tamoxifen and their molar mixtures in the same ratios as above were immersed in an excess of distilled water. As it can be observed, water dramatically changed the X-ray pattern of DMPC. In fact, its bilayer width expanded from 54.5 A when dry to 64.0 A and its reflections were reduced to only the first three orders of the bilayer Table I a) All the specimens were recrystallized from CHCl3:CH3OH 3:1 (v/v).
b) The interplanar spacings and intensities of the reflections were measured in X-ray diagrams from Debye-Scherrer and flate-plate cameras with 8 and 14*cm specimen-to-film distance. c) Only the main observed reflections are included. a) The samples were diffracted 2 days after preparation. b) The interplanar spacings and intensities of the reflections were measured in X-ray diagrams from flat-plate cameras with 8 and 14*cm specimen-to-film distance. c) Only the main observed reflections are included.
width and a relatively intense reflection of 4.2 A. The latter arose from the stiff and fully extended DMPC hydrocarbon chains organized with rota tional disorder in an hexagonal lattice. As before, increasing concentrations of tamoxifen produced a gradual decrease of the phospholipid reflection intensities without affecting its bilayer width. On the other hand, reflections arising from the drug were observed even in the 1 0 : 1 molar mixture.
These results indicated that again part of tamoxi fen, despite of its low solubility in water, was able to penetrate into DMPC bilayer perturbing its mo lecular structure. The results obtained after DM PE was made to interact with tamoxifen in the hydrophobic medium are presented in Table III and Fig. 3a , whereas those obtained in the aqueous one are shown in Table IV and Fig. 3b . As it can be appreciated, the effects of the drug upon the 
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14 7 a) All the specimens were recrystallized from CHC^CH^OH 3:1 (v/v). b) The interplanar spacings and intensities of the reflections were measured in X-ray diagrams from Debye-Scherrer and flate-plate cameras with 8 and 14*cm specimen-to-film distance. c) Only the main observed reflections are included.
structure of D M PE were considerable milder than those observed in DM PC under the same physico chemical conditions. In fact, even at such a high molar ratio as 1 : 1 tamoxifen did not induce a sig nificative perturbation to DM PE, particularly in the presence of water. The fact that the intensities of the drug reflections are practically the same when immersed in pure water and in the presence of D M PE indicated that tamoxifen failed to penet rate into the bilayer. It is also worth to note that besides a small decrease of the reflection inten sities the X-ray pattern of DM PE was not significatively affected by water.
Fluorescence measurements on large unilamellar vesicles (LUV)
The influence of tamoxifen upon the bilayer of DMPC LU V was evaluated at the phospholipid acyl chain hydrophobic core and at the hydrophi lic/hydrophobic interface, i.e., the phospholipid polar head level. This was achieved evaluating DPH steady state fluorescence anisotropy (r) and Laurdan fluorescence spectral shifts, respectively. The latter was quantified through the general po larization (GP) parameter (Parasassi and Gratton, 1995) . The presence of increasing concentrations of tamoxifen produced a significative decrease in DPH fluorescence anisotropy and Laurdan GP as a) The samples were diffracted 2 days after preparation. b) The interplanar spacings and intensities of the reflec tions were measured in X-ray diagrams from DebyeScherrer and flat-plate cameras with 8 and 14*cm specimen-to-film distance. c) Only the main observed reflections are included.
shown in Table V . The decrease of these parame ters can be explained as a disorder effect induced by tamoxifen on the acyl chain packing and an en hancement of molecular dynamics or water penet ration at the phospholipid polar head level, respec tively. The latter effects could be a consequence of a mild structural disorganization at this level.
Scanning electron microscopy (SEM ) studies on human erythrocytes
The examination by SEM of red cells incubated with tamoxifen revealed abnormalities in their shapes. In contrast to the normal discoid erythro cyte profile a great number of tamoxifen treated cells underwent stomatocytic shape changes, i.e., evagination of one surface and invagination of the opposite face. This effect was observed in all the assayed samples and the extent of the shape alter ation was always the same.
Discussion
Several controversies surround the mechanism of action of the anticancer drug tamoxifen. One of them is whether it interacts directly with a relevant membrane protein such as E R , A E B S or an en zyme (Das et al., 1993; Eyster et al., 1989; O 'Brien et al., 1988; Horgan et al., 1986) or indirectly through structural modification of the membrane where the protein is located (O 'Brien et al., 1986; Custodio et al., 1991 Custodio et al., , 1993 Luxo et al., 1996) . In order to elucidate this controversy we studied the interaction of tamoxifen with the human erythro cyte membrane and bilayers built up of DMPC and DMPE. Tamoxifen Table V . Effect of Tamoxifen on the fluorescence anisotropy (r) of l,6-diphenyl-l,3,5-hexatriene (D PH ) and the general polarization (GP) of Laurdan embedded in large unilamellar vesicles (LU V ) of dimyristoylphosphatidylcholine (DMPC) (probe:lipid ratio 1:600). The experiments performed by fluorescence spectroscopy showed that tamoxifen interacted with DMPC under the form of large unilamellar vesicles (LU V ) perturbing its polar head and hy drocarbon chain regions (Table V) . These results were confirmed by the X-ray experiments. In fact, in molar ratios similar to those used in LUV, ta moxifen was able to perturb the same molecular regions of DMPC bilayers in both the hydrophobic and aqueous media where these interactions were assayed. However, tamoxifen did not cause any significative structural effect in DM PE bilayers. This difference can be related to their respective packing arrangements and the effects of water upon them. Chemically these phospholipids only differ in their terminal amino groups, being +NH3 in DM PE and +N(CH3 ) 3 in DMPC. Moreover, both molecular conformations are very similar in their dry crystalline phases (Suwalsky, 1988) with the hydrocarbon chains mostly parallel and ex tended with the polar groups lying perpendicularly to them. However, DM PE molecules pack tighter than those of DMPC due to its smaller polar group and higher effective charge, resulting in a very sta ble multilayer system which is not significatively affected by water (Suwalsky and Duk, 1987) . On the other hand, the gradual hydration of DMPC results in water molecules occupying the highly polar interbilayer spaces. Therefore, its bilayer width increases from 54.5 A when dried up to 64.0 A when it was fully hydrated. This situation al lowed the incorporation of tamoxifen into DMPC bilayers producing its structural perturbation, which was not the case of DM PE.
The examination by electron microscopy of the erythrocytes incubated with tamoxifen revealed that they changed their normal discoid shape to stomatocytes. Accordingly to the bilayer hypothe sis, this means that the drug inserted into the inner monolayer of the erythrocyte membrane (Sheetz and Singer, 1974) . This moiety is poor in the class of lipids represented by DMPC and rich in those similar to DM PE, which did not interact with ta moxifen. Therefore, it is likely that this drug pref erentially interacted with proteins located in the inner leaflet of the membrane. This conclusion is supported by reports that 99% of medicated ta moxifen is protein-bound (Nayfield, 1995) . Pa tients are normally treated with doses of 250 mg/ kg (Jordan, 1995) , reaching a concentration of about 1 mM in the serum (Jordan, 1990) . On the other hand, the concentration of the drug and me tabolites in humans are 10-to-60-fold higher in tis sues than in serum (Lien et al., 1991) . Therefore, the concentrations used in the experiments with human erythrocytes, liposomes and phospholipid multilayers were within the range of the concen trations that are therapeutically attained.
